INMD
What one share of InMode holds
Electromedical and Electrotherapeutic Apparatus
We are a leading global provider of innovative, energy-based, minimally invasive surgical medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s wellness.
InMode’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $5.66 |
|---|---|
| Profit | $1.43 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | $1.29 |
| Cash and investments | $6.10 |
| Book value | $10.78 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.90 | $0.13 | $0.00 | $0.24 | — | $0.37 |
| 2018 | $1.43 | $0.31 | $0.01 | $0.52 | — | $0.81 |
| 2019 | $2.05 | $0.80 | $0.01 | $0.81 | — | $2.68 |
| 2020 | $2.45 | $0.89 | $0.01 | $0.94 | — | $3.36 |
| 2021 | $4.16 | $1.92 | $0.01 | $2.02 | — | $5.01 |
| 2022 | $5.32 | $1.89 | $0.02 | $2.11 | — | $6.72 |
| 2023 | $5.72 | $2.30 | $0.01 | $2.05 | — | $9.38 |
| 2024 | $4.90 | $2.25 | $0.01 | $1.64 | — | $10.12 |
| 2025 | $5.66 | $1.43 | $0.01 | $1.29 | — | $10.78 |